PARNETTI, Lucilla
 Distribuzione geografica
Continente #
NA - Nord America 9.603
EU - Europa 6.852
AS - Asia 3.084
SA - Sud America 120
AF - Africa 27
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 11
Totale 19.713
Nazione #
US - Stati Uniti d'America 9.576
IE - Irlanda 1.739
UA - Ucraina 1.407
SG - Singapore 1.260
IT - Italia 1.184
HK - Hong Kong 715
SE - Svezia 705
VN - Vietnam 480
DE - Germania 425
FI - Finlandia 404
CN - Cina 393
RU - Federazione Russa 320
FR - Francia 151
GB - Regno Unito 127
BR - Brasile 108
RO - Romania 75
TR - Turchia 67
KR - Corea 63
AT - Austria 55
CH - Svizzera 55
NL - Olanda 44
BE - Belgio 42
CZ - Repubblica Ceca 34
UZ - Uzbekistan 28
GR - Grecia 22
PL - Polonia 21
EG - Egitto 18
CA - Canada 16
ES - Italia 12
EU - Europa 11
JP - Giappone 11
LB - Libano 11
NZ - Nuova Zelanda 10
IR - Iran 8
AM - Armenia 7
MX - Messico 7
AU - Australia 6
IN - India 5
SK - Slovacchia (Repubblica Slovacca) 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
LT - Lituania 4
PH - Filippine 4
PK - Pakistan 4
TW - Taiwan 4
AZ - Azerbaigian 3
BG - Bulgaria 3
MA - Marocco 3
PT - Portogallo 3
PY - Paraguay 3
VE - Venezuela 3
BD - Bangladesh 2
CL - Cile 2
CO - Colombia 2
HR - Croazia 2
JO - Giordania 2
KE - Kenya 2
NO - Norvegia 2
RS - Serbia 2
TJ - Tagikistan 2
TN - Tunisia 2
AL - Albania 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
EC - Ecuador 1
GE - Georgia 1
ID - Indonesia 1
IL - Israele 1
IQ - Iraq 1
IS - Islanda 1
JM - Giamaica 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
PA - Panama 1
PE - Perù 1
SA - Arabia Saudita 1
SV - El Salvador 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 19.713
Città #
Chandler 1.966
Dublin 1.738
Singapore 958
San Mateo 850
Jacksonville 745
Hong Kong 705
Boardman 682
Dong Ket 479
Altamura 474
Santa Clara 473
Medford 405
Princeton 402
Wilmington 357
Lawrence 355
Perugia 339
Ann Arbor 259
Des Moines 247
Andover 184
Beijing 156
Saint Petersburg 121
Ashburn 119
Helsinki 104
San Paolo di Civitate 94
Falls Church 93
Los Angeles 92
Norwalk 73
Woodbridge 66
Izmir 60
Seoul 60
Redmond 54
Brussels 39
Rome 36
Timisoara 35
Bucharest 34
Munich 30
Nuremberg 30
Dallas 29
Redwood City 27
Moscow 25
New York 25
Houston 24
Shanghai 22
Den Haag 20
Lausanne 19
Auburn Hills 17
Fairfield 17
Lappeenranta 16
Frankfurt Am Main 14
Vienna 14
Brno 13
Milan 12
Paris 11
Saint Louis 11
Bologna 10
Giza 10
Amsterdam 9
Florence 9
Frankfurt am Main 9
San Diego 9
Tappahannock 9
Chicago 8
Olomouc 8
Seattle 8
Tokyo 8
Toronto 8
Auckland 7
Ardabil 6
Madrid 6
Monmouth Junction 6
Naples 6
São Paulo 6
Tashkent 6
Turin 6
Yerevan 6
Fremont 5
Guangzhou 5
Mcallen 5
Ottawa 5
Adelaide 4
Belo Horizonte 4
Bratislava 4
Cava de' Tirreni 4
Curitiba 4
Hanover 4
Istanbul 4
London 4
Newark 4
Philadelphia 4
Praia Grande 4
Shenzhen 4
Terni 4
Zhengzhou 4
Al Mansurah 3
Atlanta 3
Baku 3
Brescia 3
Cambridge 3
Clifton 3
Duino-Aurisina 3
Edinburgh 3
Totale 13.490
Nome #
Apopoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer’s disease and vascular dementia patients 120
CSF and blood biomarkers for Parkinson's disease 120
A new assay for antiphospholipid antibodies in patient with ischemic stroke 116
Platelet MAO-B activity and vitamin B12 in old age dementias. 104
Effect of acetyl-L-carnitine on serum levels of cortisol and adrenocorticotropic hormone and its clinical effect in patients with senile dementia of Alzheimer type 99
102.Evolutionary trends in carotid atherosclerotic plaques: results of a two-year follow-up study using an ultrasound imaging system. 98
First-ever stroke and outcome in patients admitted to Perugia Stroke Unit:predictors for death, dependency, and recurrence of stroke within the first three months. 97
Changes in CSF acetyl- and butyrylcholinesterase activity after long-term treatment with AChE inhibitors in Alzheimer's disease. 95
a-D-Mannosidses in patients with familial Alzheimer's Disease 94
Brain SPECT in pathological aging brain: Alzheimer's disease, mild cognitive impairment and age-associated cognitive impairment. 93
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 93
a-D-Mannosidases in patients with Alzheimer's disease 90
Swalloving dysfunction: neurovascolar- anatomical correlation. 87
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 84
Acetylcholinesterase and butyrylcholinesterase activity in cerebrospinal fluid of Alzheimer patients before and after 6-months treatment with donepezil. XXXI Congresso Società Italiana di Neurologia 82
Risk factors and stroke subtypes: results of five consecutive years of the Perugia Stroke Registry 80
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type 79
Brain SPECT in pathological aging brain: Alzheimer’s disease, mild cognitive impairment and age-associated cognitive impairment 79
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 79
Expression of d-mannosidase in amyotrophic lateral sclerosis and Alzheimer's disease 78
Stroke related to carotid artery dissection in a young patient with Takayasu arteritis, systemic lupus erythematosus and antiphospholipid antibody syndrome. 78
Variazioni di attività della paraoxonasi serica nella fase acuta dello stroke ischemico. Stroke'99 Meeting on Cerebrovascular Diseases 77
Neuropsychological results of long-term therapy with oxiracetam in DAT/MID patients in comparison with a control group 77
Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. 77
Cerebrospinal fluid biomarkers in Parkinson disease. 76
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 76
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 76
Blood pressure and functional aspects of the aging brain. 75
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 75
CSF and Blood Biomarkers in Neuroinflammatory and Neurodegenerative Diseases: Implications for Treatment 75
Neuroendocrine markers in aging brain: clinical and neurobiological significance of dexamethasone suppression test 74
Vascular cognitive impairment: a pragmatic concept 74
Cerebrospinal fluid biomarkers and white matter lesions: can we know more? 74
99mTc-HMPAO-SPECT nell'invecchiamento cerebrale fisiologico, nei deficit di memoria età correlati e nella malattia di Alzheimer: studio longitudinale a un anno. 74
Early admission to stroke unit influences clinical outcome 74
1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease. 74
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI) 74
Repeatable Battery for the Assessment of Neuropsychological Status: Italian Normative Data for Older Adults 73
Antihistone and anti-dsDNA autoantibodies in Alzheimer's disease and vascular dementia. 73
99mTc-HMPAO cerebral SPECT in cerebrovascular disease with and without dementia. 73
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. 73
The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers. 73
B-mode imaging and histomorphometric evaluation of carotid atherosclerosis. 73
[Whole blood filterability in chronic cerebrovascular disorders: effects of the use of buflomedil hydrochloride]. 73
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology 73
Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis 73
Influence of dementia on antithrombotic therapy prescribed before stroke in patients with atrial fibrillation. 72
Performance of Aβ1-40, Aβ1-42, Total Tau, and Phosphorylated Tau as Predictors of Dementia in a Cohort of Patients with Mild Cognitive Impairment. 72
The role of haemorheological factors in the ageing brain: long-term therapy with pentoxifylline ('Trental' 400) in elderly patients with initial mental deterioration. 72
Brain SPECT in the diagnosis of degenerative dementia. 71
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease 71
Hippocampal epileptogenesis in autoimmune encephalitis 71
Association between migraine and headache attributed to stroke: a case-control study. 70
Atrial fibrillation in patients with first-ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome 70
Memantine reduces neuronal dysfunctions triggered by in vitro ischemia and 3-nitropropionic acid. 69
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation 69
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 69
Acetyl-L-carnitine in the treatment of mildly demented elderly patients. 68
Apolipoprotein-E genotype in normal aging, age-associated memory impairment, Alzheimer's disease and vascular dementia patients. 68
Neurotransmitter deficits in behavioural and psychological symptoms of Alzheimer's disease. 67
Brain SPECT in pathological aging brain: Lewy Body Disease and Age-Associated Memory Impairment. 67
Cerebrospinal fluid acetylcholinesterase activity after long-term treatment with donepezil and rivastigmina. 67
Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids 67
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies 67
Epilepsy, amyloid-β, and D1 dopamine receptors: a possible pathogenetic link? 66
Lysosomal enzymes in Parkinson's disease 66
Italian frontotemporal dementia network (FTD group-SINDEM): Sharing clinical and diagnostic procedures in Frontotemporal dementia in Italy 66
99mTc-HMPAO-SPECT contribution in the differential diagnosis of cognitive dysfunction. 65
Posatirelin for the treatment of late-onset Alzheimer's disease: a double-blind multicentre study vs citicoline and ascorbic acid. 65
Aniracetam (Ro 13-5057) in the treatment of senile dementia of Alzheimer type (SDAT): results of a placebo controlled multicentre clinical study. 65
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 65
Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies. 64
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study 64
Activation of the contact system in cerebrospinal fluid of patients with Alzheimer disease. 63
Efficacy of thrombolytic (rt-PA) therapy in old stroke patients: the Perugia Stroke Unit experience 63
Activation of complement and contact system in Alzheimer’s disease 63
A/T/(N) Profile in Cerebrospinal Fluid of Parkinson's Disease with/without Cognitive Impairment and Dementia with Lewy Bodies 63
White matter changes in stroke patients. Relationship with stroke subtype and outcome. 62
Brain SPECT in different dementia disorders: AD, Possible AD, Preclinical AD, AAMI, FTD, LBD, VaD, secondary dementia. 62
Selection of thrombogenetic antiphospholipid antibodies in cerebrovascular disease patients. 62
Semi-quantitative analysis of perfusion of Brodmann areas in the differential diagnosis of cognitive impairment in Alzheimer's disease, fronto-temporal dementia and mild cognitive impairment. 62
Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia 62
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction 62
Serum anti-GFAP and anti-S100 autoantibodies in brain aging, Alzheimer's disease and vascular dementia. 62
A magnetization transfer study of mild and advanced Parkinson's disease. 62
[Drinking-water and cardiovascular mortality]. 61
Carotid atherosclerotic disease: role of hypertension and other risk factors. 61
Arterial hypertension and stroke prevention: an update. 60
Comparative kinetics of oxiracetam in serum and CSF of patients with dementia of Alzheimer type. 60
Is multi-infarct dementia representative of vascular dementias? A retrospective study 59
A combination of CSF Tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsy. 59
Are we ready for detecting α-synuclein prone to aggregation in patients? The case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as diagnostic tools 59
Le emozioni nei contesti individuali e sociali 59
Abnormalities of resting-state EEG in patients with prodromal and overt dementia with Lewy bodies: Relation to clinical symptoms 59
Differences in Extracellular Matrix Production and Basic Fibroblast Growth Factor Response in Skin Fibroblasts from Sporadic and Familial Alzheimer’s Disease 59
Lysosomial hydrolase in cerebrospinal fluid from subjects with Parkinson's disease 58
Young Neurologists and Trainees Stroke Subspecialty Working Group. Educational approach on stroke training in Europe. 58
Atrial fibrillation and stroke. 58
Cerebrospinal fluid neuron-specific enolase in Alzheimer's disease and vascular dementia. 58
Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. 57
Totale 7.270
Categoria #
all - tutte 103.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.703


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020682 0 0 0 0 0 0 0 35 281 139 77 150
2020/20213.135 16 204 90 217 989 137 202 39 340 123 240 538
2021/20223.192 80 580 88 141 96 85 53 944 100 131 372 522
2022/20236.532 437 1.297 81 564 491 799 15 271 2.295 18 197 67
2023/20242.424 184 280 126 59 27 14 463 97 273 99 397 405
2024/20252.658 86 606 234 283 761 351 191 146 0 0 0 0
Totale 20.562